Menu

• Ask a Health Expert about ENDOTOXIC SHOCK
• Post Your Side Effect related to ENDOTOXIC SHOCK
• ENDOTOXIC SHOCK and FDA Warnings
• ENDOTOXIC SHOCK in Patients Wiki
• Report ENDOTOXIC SHOCK in Drug Side Effect Survey

ENDOTOXIC SHOCK side effect

What is ENDOTOXIC SHOCK ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Voltaren Side Effects Report #5407280-4
Physician from JAPAN reported VOLTAREN problem on July 27, 2007. Male patient, weighting 154.3 lb, was diagnosed with pain and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: endotoxic shock, sepsis, . VOLTAREN dosage: 50 MG/DAY. Patient died.

Cellcept Side Effects Report #5344173-5
CELLCEPT problem was reported by a Physician from JAPAN on May 23, 2007. Male patient, 18 years of age, weighting 105.8 lb, was diagnosed with prophylaxis against graft versus host disease, hepatic vein occlusion, pyrexia, polyuria, blood pressure decreased, hepatic function abnormal and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: abdominal distension, endotoxic shock, . CELLCEPT dosage: unknown. During the same period patient was treated with FINIBAX, ALPROSTADIL, ACYCLOVIR, INOVAN, DILTIAZEM, NEO MINOPHAGEN C. Patient died on 03/10/2007.

Cellcept Side Effects Report #5332546-6
Physician from JAPAN reported CELLCEPT problem on May 11, 2007. Male patient, 18 years of age, weighting 105.8 lb, was diagnosed with prophylaxis against graft versus host disease and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: abdominal distension, endotoxic shock, . CELLCEPT dosage: unknown. During the same period patient was treated with FINIBAX, ALPROSTADIL, ACYCLOVIR, INOVAN, DILTIAZEM, NEO MINOPHAGEN C. Patient died on 03/10/2007.

Abraxane Side Effects Report #5664768-9
ABRAXANE problem was reported by a Physician from UNITED STATES on Feb 26, 2008. Female patient, 61 years of age, weighting 187.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, colitis ischaemic, endotoxic shock, metastases to lung, neutropenia, pneumonia, renal failure acute, septic shock, . ABRAXANE dosage: LAST DOSE (200 MG) PRIOR TO SAE ON 05-FEB-2008 (CYCLE 5) (WEEKLY, 3WKS ON THEN 1 WK. OFF), INTRAVENO. During the same period patient was treated with KYTRIL, DECADRON, TOPROL, ACIPHEX, LASIX, GABAPENTIN, CYMBALTA, ZAROXOLYN. Patient was hospitalized. Patient recovered.